Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 10,381.94 million compared to CNY 8,056.12 million a year ago. Revenue was CNY 10,381.94 million compared to CNY 8,056.12 million a year ago. Net income was CNY 462.51 million compared to CNY 847.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.33 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.33 a year ago.